Emtricitabine
(Emtriva®) (Oral presentations) - Formulary
|
Nucleoside reverse transcriptase inhibitors 05.03.01 |
Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg
(Eviplera®) - Formulary
|
Nucleoside reverse transcriptase inhibitors 05.03.01 |
Emtricitabine with rilpivirine and tenofovir alafenamide
( Odefsey® ) - Formulary
|
Nucleoside reverse transcriptase inhibitors 05.03.01 |
Emtricitabine with tenofovir alafenamide
(Descovy®) - Formulary
|
Nucleoside reverse transcriptase inhibitors 05.03.01 |
Emtricitabine with tenofovir disoproxil
- Formulary
|
Nucleoside reverse transcriptase inhibitors 05.03.01 |
Emtricitabine with tenofovir disoproxil
(Truvada®) - Non Formulary
|
Nucleoside reverse transcriptase inhibitors 05.03.01 |
Emtricitabine with tenofovir disoproxil
(Ictastan®) - Non Formulary
|
Nucleoside reverse transcriptase inhibitors 05.03.01 |